SINOPHARM GROUP (Germany) Market Value
| X2S1 Stock | EUR 11.20 0.10 0.88% |
| Symbol | SINOPHARM |
SINOPHARM GROUP 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to SINOPHARM GROUP's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of SINOPHARM GROUP.
| 10/25/2025 |
| 01/23/2026 |
If you would invest 0.00 in SINOPHARM GROUP on October 25, 2025 and sell it all today you would earn a total of 0.00 from holding SINOPHARM GROUP 15ON or generate 0.0% return on investment in SINOPHARM GROUP over 90 days. SINOPHARM GROUP is related to or competes with GRENKELEASING, ALBIS LEASING, Virtus Investment, AOYAMA TRADING, UNITED RENTALS, Westshore Terminals, and Air Lease. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and medical devices and heal... More
SINOPHARM GROUP Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure SINOPHARM GROUP's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess SINOPHARM GROUP 15ON upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 1.28 | |||
| Information Ratio | (0) | |||
| Maximum Drawdown | 7.05 | |||
| Value At Risk | (1.74) | |||
| Potential Upside | 1.89 |
SINOPHARM GROUP Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for SINOPHARM GROUP's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as SINOPHARM GROUP's standard deviation. In reality, there are many statistical measures that can use SINOPHARM GROUP historical prices to predict the future SINOPHARM GROUP's volatility.| Risk Adjusted Performance | 0.0623 | |||
| Jensen Alpha | 0.1086 | |||
| Total Risk Alpha | (0.07) | |||
| Sortino Ratio | (0) | |||
| Treynor Ratio | (0.44) |
SINOPHARM GROUP January 23, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0623 | |||
| Market Risk Adjusted Performance | (0.43) | |||
| Mean Deviation | 0.9132 | |||
| Semi Deviation | 0.8137 | |||
| Downside Deviation | 1.28 | |||
| Coefficient Of Variation | 1269.0 | |||
| Standard Deviation | 1.26 | |||
| Variance | 1.6 | |||
| Information Ratio | (0) | |||
| Jensen Alpha | 0.1086 | |||
| Total Risk Alpha | (0.07) | |||
| Sortino Ratio | (0) | |||
| Treynor Ratio | (0.44) | |||
| Maximum Drawdown | 7.05 | |||
| Value At Risk | (1.74) | |||
| Potential Upside | 1.89 | |||
| Downside Variance | 1.65 | |||
| Semi Variance | 0.6621 | |||
| Expected Short fall | (1.62) | |||
| Skewness | 0.8821 | |||
| Kurtosis | 1.68 |
SINOPHARM GROUP 15ON Backtested Returns
At this point, SINOPHARM GROUP is not too volatile. SINOPHARM GROUP 15ON owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0795, which indicates the firm had a 0.0795 % return per unit of standard deviation over the last 3 months. We have found twenty-seven technical indicators for SINOPHARM GROUP 15ON, which you can use to evaluate the volatility of the company. Please validate SINOPHARM GROUP's risk adjusted performance of 0.0623, and Coefficient Of Variation of 1269.0 to confirm if the risk estimate we provide is consistent with the expected return of 0.1%. SINOPHARM GROUP has a performance score of 6 on a scale of 0 to 100. The entity has a beta of -0.2, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning SINOPHARM GROUP are expected to decrease at a much lower rate. During the bear market, SINOPHARM GROUP is likely to outperform the market. SINOPHARM GROUP 15ON currently has a risk of 1.27%. Please validate SINOPHARM GROUP total risk alpha, treynor ratio, value at risk, as well as the relationship between the sortino ratio and maximum drawdown , to decide if SINOPHARM GROUP will be following its existing price patterns.
Auto-correlation | -0.02 |
Very weak reverse predictability
SINOPHARM GROUP 15ON has very weak reverse predictability. Overlapping area represents the amount of predictability between SINOPHARM GROUP time series from 25th of October 2025 to 9th of December 2025 and 9th of December 2025 to 23rd of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of SINOPHARM GROUP 15ON price movement. The serial correlation of -0.02 indicates that only 2.0% of current SINOPHARM GROUP price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.02 | |
| Spearman Rank Test | 0.06 | |
| Residual Average | 0.0 | |
| Price Variance | 0.07 |
Currently Active Assets on Macroaxis
Other Information on Investing in SINOPHARM Stock
SINOPHARM GROUP financial ratios help investors to determine whether SINOPHARM Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in SINOPHARM with respect to the benefits of owning SINOPHARM GROUP security.